Mercer Global Advisors Inc. ADV Has $1.24 Million Holdings in Smith & Nephew plc (NYSE:SNN)

Mercer Global Advisors Inc. ADV cut its position in Smith & Nephew plc (NYSE:SNN - Free Report) by 22.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 50,354 shares of the medical equipment provider's stock after selling 14,481 shares during the quarter. Mercer Global Advisors Inc. ADV's holdings in Smith & Nephew were worth $1,238,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. PNC Financial Services Group Inc. raised its stake in shares of Smith & Nephew by 4.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,120 shares of the medical equipment provider's stock valued at $224,000 after purchasing an additional 399 shares in the last quarter. National Bank of Canada FI lifted its stake in shares of Smith & Nephew by 36.5% in the 4th quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider's stock worth $41,000 after acquiring an additional 446 shares during the period. Bleakley Financial Group LLC boosted its holdings in shares of Smith & Nephew by 3.5% in the fourth quarter. Bleakley Financial Group LLC now owns 17,704 shares of the medical equipment provider's stock valued at $435,000 after acquiring an additional 596 shares in the last quarter. Signaturefd LLC increased its stake in shares of Smith & Nephew by 4.3% during the fourth quarter. Signaturefd LLC now owns 15,772 shares of the medical equipment provider's stock valued at $388,000 after acquiring an additional 653 shares during the period. Finally, Principal Securities Inc. raised its holdings in Smith & Nephew by 87.6% during the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider's stock worth $36,000 after purchasing an additional 691 shares in the last quarter. Institutional investors own 25.64% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Canaccord Genuity Group lifted their price target on Smith & Nephew from $27.00 to $28.00 and gave the company a "hold" rating in a research report on Thursday, May 1st. UBS Group lowered shares of Smith & Nephew from a "buy" rating to a "neutral" rating in a research report on Wednesday, March 12th. HSBC lowered shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Friday, April 25th. StockNews.com upgraded shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a report on Wednesday, February 26th. Finally, Hsbc Global Res downgraded Smith & Nephew from a "strong-buy" rating to a "hold" rating in a research note on Friday, April 25th. Six equities research analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, Smith & Nephew presently has a consensus rating of "Hold" and an average price target of $28.00.

Smith & Nephew Stock Up 2.5%

Shares of NYSE:SNN traded up $0.71 during midday trading on Thursday, hitting $28.68. 279,219 shares of the stock were exchanged, compared to its average volume of 806,037. The company has a market capitalization of $12.56 billion, a PE ratio of 13.27, a P/E/G ratio of 1.26 and a beta of 0.68. Smith & Nephew plc has a 52-week low of $23.69 and a 52-week high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The business's fifty day simple moving average is $27.46 and its two-hundred day simple moving average is $26.28.

Smith & Nephew Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 28th. Investors of record on Friday, March 28th will be given a dividend of $0.447 per share. This represents a yield of 2.5%. The ex-dividend date is Friday, March 28th. This is a positive change from Smith & Nephew's previous semi-annual dividend of $0.29. Smith & Nephew's dividend payout ratio (DPR) is presently 41.20%.

Smith & Nephew Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.